-
1
-
-
0033304888
-
Polycystic ovary syndrome (PCOS): Arguably the most common endocrinopathy is associated with significant morbidity in women
-
Carmina E, Lobo RA 1999 Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 84:1897-1899
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 1897-1899
-
-
Carmina, E.1
Lobo, R.A.2
-
2
-
-
0035955884
-
Polycystic ovary syndrome: The new millenium
-
Legro RS 2001 Polycystic ovary syndrome: the new millenium. Mol Cell Endocrinol 184:87-93
-
(2001)
Mol Cell Endocrinol
, vol.184
, pp. 87-93
-
-
Legro, R.S.1
-
3
-
-
0035655992
-
Obesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinemia, dyslipidemia and hypertension in ageing women with polycystic ovary syndrome
-
Oxf
-
Elting MW, Korsen TJM, Shoemaker J 2001 Obesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinemia, dyslipidemia and hypertension in ageing women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 55:767-776
-
(2001)
Clin Endocrinol
, vol.55
, pp. 767-776
-
-
Elting, M.W.1
Korsen, T.J.M.2
Shoemaker, J.3
-
4
-
-
0035900614
-
Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue
-
Halleux CM, Takahashi M, Delporte ML, Detry R, Funahashi T, Matsuzawa Y, Brichard SM 2001 Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun 288:1102-1007
-
(2001)
Biochem Biophys Res Commun
, vol.288
, pp. 1102-11007
-
-
Halleux, C.M.1
Takahashi, M.2
Delporte, M.L.3
Detry, R.4
Funahashi, T.5
Matsuzawa, Y.6
Brichard, S.M.7
-
5
-
-
0033924289
-
Genomic structure and mutations in adipose-specific gene, adiponectin
-
Takahashi M, Arita Y, Yamagata K, Matsuzawa Y, Okutomi K, Horie M, Shimomura I, Hotta K, Kuriyama H, Kihara S, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y 2000 Genomic structure and mutations in adipose-specific gene, adiponectin. Int J Obes 24:861-868
-
(2000)
Int J Obes
, vol.24
, pp. 861-868
-
-
Takahashi, M.1
Arita, Y.2
Yamagata, K.3
Matsuzawa, Y.4
Okutomi, K.5
Horie, M.6
Shimomura, I.7
Hotta, K.8
Kuriyama, H.9
Kihara, S.10
Nakamura, T.11
Yamashita, S.12
Funahashi, T.13
Matsuzawa, Y.14
-
6
-
-
0035462629
-
PPARy ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein
-
Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y 2001 PPARy ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50:2094-2099
-
(2001)
Diabetes
, vol.50
, pp. 2094-2099
-
-
Maeda, N.1
Takahashi, M.2
Funahashi, T.3
Kihara, S.4
Nishizawa, H.5
Kishida, K.6
Nagaretani, H.7
Matsuda, M.8
Komuro, R.9
Ouchi, N.10
Kuriyama, H.11
Hotta, K.12
Nakamura, T.13
Shimomura, I.14
Matsuzawa, Y.15
-
7
-
-
0036481709
-
Synthetic peroxisome proliferator-activated receptor y agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients
-
Yang WS, Leng CY, Wu TJ, Tanaka S, Funahashi T, Matsuzawa Y, Wang JP, Chen CL, Tai TY, Chuang LM 2002 Synthetic peroxisome proliferator-activated receptor y agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care 25:376-380
-
(2002)
Diabetes Care
, vol.25
, pp. 376-380
-
-
Yang, W.S.1
Leng, C.Y.2
Wu, T.J.3
Tanaka, S.4
Funahashi, T.5
Matsuzawa, Y.6
Wang, J.P.7
Chen, C.L.8
Tai, T.Y.9
Chuang, L.M.10
-
8
-
-
0345164399
-
Molecular scanning of the human peroxisome proliferator activated receptor γ (hPPARγ) gene in diabetic Caucasians: Identification of a Pro12Ala PPARγ2 missense mutation
-
Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, Burns DK, Roth J, Shuldiner AR 1997 Molecular scanning of the human peroxisome proliferator activated receptor γ (hPPARγ) gene in diabetic Caucasians: identification of a Pro12Ala PPARγ2 missense mutation. Biochem Biophys Res Commun 241:270-274
-
(1997)
Biochem Biophys Res Commun
, vol.241
, pp. 270-274
-
-
Yen, C.J.1
Beamer, B.A.2
Negri, C.3
Silver, K.4
Brown, K.A.5
Yarnall, D.P.6
Burns, D.K.7
Roth, J.8
Shuldiner, A.R.9
-
9
-
-
0033515761
-
Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity
-
Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa JI, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y 1999 Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83
-
(1999)
Biochem Biophys Res Commun
, vol.257
, pp. 79-83
-
-
Arita, Y.1
Kihara, S.2
Ouchi, N.3
Takahashi, M.4
Maeda, K.5
Miyagawa, J.I.6
Hotta, K.7
Shimomura, I.8
Nakamura, T.9
Miyaoka, K.10
Kuriyama, H.11
Nishida, M.12
Yamashita, S.13
Okubo, K.14
Matsubara, K.15
Muraguchi, M.16
Ohmoto, Y.17
Funahashi, T.18
Matsuzawa, Y.19
-
10
-
-
0034891684
-
Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin
-
Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsazawa Y, Chao CL, Chen CL, Tai TY, Chuang LM 2001 Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86:3815-3819
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 3815-3819
-
-
Yang, W.S.1
Lee, W.J.2
Funahashi, T.3
Tanaka, S.4
Matsazawa, Y.5
Chao, C.L.6
Chen, C.L.7
Tai, T.Y.8
Chuang, L.M.9
-
11
-
-
0036075053
-
Decreased plasma adiponectin concentrations in women with dyslipidemia
-
Matsubara M, Maruoka S, Katayose S 2002 Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 87:2764-2769
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 2764-2769
-
-
Matsubara, M.1
Maruoka, S.2
Katayose, S.3
-
12
-
-
0034999667
-
Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia
-
Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tateranni A 2001 Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 1930-1935
-
-
Weyer, C.1
Funahashi, T.2
Tanaka, S.3
Hotta, K.4
Matsuzawa, Y.5
Pratley, R.E.6
Tateranni, A.7
-
13
-
-
0037135523
-
Disruption of adiponectin causes insulin resistance and neointimal formation
-
Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, Yano W, Froge P, Nagai R, Rimura S, Kadiwaki T, Noda T 2002 Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277:25863-25866
-
(2002)
J Biol Chem
, vol.277
, pp. 25863-25866
-
-
Kubota, N.1
Terauchi, Y.2
Yamauchi, T.3
Kubota, T.4
Moroi, M.5
Matsui, J.6
Eto, K.7
Yamashita, T.8
Kamon, J.9
Satoh, H.10
Yano, W.11
Froge, P.12
Nagai, R.13
Rimura, S.14
Kadiwaki, T.15
Noda, T.16
-
14
-
-
0036303146
-
Association of adiponectin mutation with type 2 diabetes
-
Kondo H, Shimomura I, Matsukawa Y, Takahashi M, Matsuda M, Ouchi N, Kihara S, Kanamoto T, Sumitsuji S, Funahashi T, Matsuzawa Y 2002 Association of adiponectin mutation with type 2 diabetes. Diabetes 51:2325-2328
-
(2002)
Diabetes
, vol.51
, pp. 2325-2328
-
-
Kondo, H.1
Shimomura, I.2
Matsukawa, Y.3
Takahashi, M.4
Matsuda, M.5
Ouchi, N.6
Kihara, S.7
Kanamoto, T.8
Sumitsuji, S.9
Funahashi, T.10
Matsuzawa, Y.11
-
15
-
-
0036511213
-
ACRP30/adiponectin: An adipokine regulating glucose and lipid metabolism
-
Berg AH, Combs TP, Scherer PE 2002 ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13:84-89
-
(2002)
Trends Endocrinol Metab
, vol.13
, pp. 84-89
-
-
Berg, A.H.1
Combs, T.P.2
Scherer, P.E.3
-
16
-
-
0036598335
-
Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure
-
Kazumi T, Kawaguchi A, Sakai K, Hirano T, Yoshino G 2002 Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 25:971-976
-
(2002)
Diabetes Care
, vol.25
, pp. 971-976
-
-
Kazumi, T.1
Kawaguchi, A.2
Sakai, K.3
Hirano, T.4
Yoshino, G.5
-
17
-
-
0037629987
-
Adiponectin levels in women with polycystic ovary syndrome
-
Orio Jr F, Palomba S, Cascella T, Milan G, Mioni R, Pagano C, Zullo F, Colao A, Lombardi G, Vettor R 2003 Adiponectin levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:2619-2623
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 2619-2623
-
-
Orio Jr., F.1
Palomba, S.2
Cascella, T.3
Milan, G.4
Mioni, R.5
Pagano, C.6
Zullo, F.7
Colao, A.8
Lombardi, G.9
Vettor, R.10
-
18
-
-
9144230787
-
Exon 6 and 2 peroxisome proliferator-activated receptor-γ polymorphisms in polycystic ovary syndrome
-
Orio Jr F, Matarese G, Di Biase S, Palomba S, Labella D, Sanna V, Savastano S, Zullo F, Colao A, Lombardi G 2003 Exon 6 and 2 peroxisome proliferator-activated receptor-γ polymorphisms in polycystic ovary syndrome. J Clin Endocrinol Metab 88:5887-5892
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 5887-5892
-
-
Orio Jr., F.1
Matarese, G.2
Di Biase, S.3
Palomba, S.4
Labella, D.5
Sanna, V.6
Savastano, S.7
Zullo, F.8
Colao, A.9
Lombardi, G.10
-
19
-
-
0031595923
-
A Pro12Ala substitution in PPArγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
-
Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J 1998 A Pro12Ala substitution in PPArγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284-287
-
(1998)
Nat Genet
, vol.20
, pp. 284-287
-
-
Deeb, S.S.1
Fajas, L.2
Nemoto, M.3
Pihlajamaki, J.4
Mykkanen, L.5
Kuusisto, J.6
Laakso, M.7
Fujimoto, W.8
Auwerx, J.9
-
20
-
-
0033304551
-
Two polymorphisms in the peroxisome proliferator-activated receptor-γ gene are associated with severe overweight among obese women
-
Valve R, Sivenius K, Miettinen R, Pihlajamaki J, Rissanen A, Deeb SS, Auwerx J, Uusitupa M, Laakso M 1999 Two polymorphisms in the peroxisome proliferator-activated receptor-γ gene are associated with severe overweight among obese women. J Clin Endocrinol Metab 84:3708-3712
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 3708-3712
-
-
Valve, R.1
Sivenius, K.2
Miettinen, R.3
Pihlajamaki, J.4
Rissanen, A.5
Deeb, S.S.6
Auwerx, J.7
Uusitupa, M.8
Laakso, M.9
-
21
-
-
0031667127
-
Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations
-
Beamer BA, Yen CJ, Andersen RE, Muller D, Elahi D, Cheskin LJ, Andres R, Roth J, Shuldiner AR 1998 Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations. Diabetes 47:1806-1808
-
(1998)
Diabetes
, vol.47
, pp. 1806-1808
-
-
Beamer, B.A.1
Yen, C.J.2
Andersen, R.E.3
Muller, D.4
Elahi, D.5
Cheskin, L.J.6
Andres, R.7
Roth, J.8
Shuldiner, A.R.9
-
23
-
-
0033626426
-
The PPARγ2 polymorphism Pro12Ala is associated with better insulin sensitivity in the offspring of type 2 diabetic patients
-
Jacob S, Stumvoll M, Becker R, Koch M, Nielsen M, Loblein K, Maerker E, Volk A, Renn W, Balletshofer B, Machicao F, Rett K, Haring HU 2000 The PPARγ2 polymorphism Pro12Ala is associated with better insulin sensitivity in the offspring of type 2 diabetic patients. Horm Metab Res 32:413-416
-
(2000)
Horm Metab Res
, vol.32
, pp. 413-416
-
-
Jacob, S.1
Stumvoll, M.2
Becker, R.3
Koch, M.4
Nielsen, M.5
Loblein, K.6
Maerker, E.7
Volk, A.8
Renn, W.9
Balletshofer, B.10
Machicao, F.11
Rett, K.12
Haring, H.U.13
-
24
-
-
0034728762
-
The Pro12Ala polymorphism in PPAR γ2 may confer resistance to type 2 diabetes
-
Hara K, Okada T, Tobe K, Yasuda K, Mori Y, Kadowaki H, Hagura R, Akanuma Y, Kimura S, Ito C, Kadowaki T 2000 The Pro12Ala polymorphism in PPAR γ2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun 271:212-216
-
(2000)
Biochem Biophys Res Commun
, vol.271
, pp. 212-216
-
-
Hara, K.1
Okada, T.2
Tobe, K.3
Yasuda, K.4
Mori, Y.5
Kadowaki, H.6
Hagura, R.7
Akanuma, Y.8
Kimura, S.9
Ito, C.10
Kadowaki, T.11
-
25
-
-
0034745185
-
The Pro12→Ala substitution in PPAR-γ is associated with resistance to development of diabetes in the general population: Possible involvement in impairment of insulin secretion in individuals with type 2 diabetes
-
Mori H, Ikegami H, Kawaguchi Y, Seino S, Yokoi N, Takeda J, Inoue I, Seino Y, Yasuda K, Hanafusa T, Yamagata K, Awata T, Kadowaki T, Hara K, Yamada N, Gotoda T, Iwasaki N, Iwamoto Y, Sanke T, Nanjo K, Oka Y, Matsutani A, Maeda E, Kasuga M 2001 The Pro12→Ala substitution in PPAR-γ is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes 50:891-894
-
(2001)
Diabetes
, vol.50
, pp. 891-894
-
-
Mori, H.1
Ikegami, H.2
Kawaguchi, Y.3
Seino, S.4
Yokoi, N.5
Takeda, J.6
Inoue, I.7
Seino, Y.8
Yasuda, K.9
Hanafusa, T.10
Yamagata, K.11
Awata, T.12
Kadowaki, T.13
Hara, K.14
Yamada, N.15
Gotoda, T.16
Iwasaki, N.17
Iwamoto, Y.18
Sanke, T.19
Nanjo, K.20
Oka, Y.21
Matsutani, A.22
Maeda, E.23
Kasuga, M.24
more..
-
26
-
-
0036125944
-
Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes
-
Hirose H, Kawai T, Yamamoto Y, Taniyama M, Tomita M, Matsubara K, Okazaki Y, Ishii T, Oguma Y, Takei I, Saruta T 2002 Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes. Metabolism 51:314-317
-
(2002)
Metabolism
, vol.51
, pp. 314-317
-
-
Hirose, H.1
Kawai, T.2
Yamamoto, Y.3
Taniyama, M.4
Tomita, M.5
Matsubara, K.6
Okazaki, Y.7
Ishii, T.8
Oguma, Y.9
Takei, I.10
Saruta, T.11
-
27
-
-
0036835826
-
2 gene Pro12Ala polymorphism may influence serum level of an adipocyte-derived protein, adiponectin, in the Japanese population
-
2 gene Pro12Ala polymorphism may influence serum level of an adipocyte-derived protein, adiponectin, in the Japanese population. Metabolism 51:1407-1409
-
(2002)
Metabolism
, vol.51
, pp. 1407-1409
-
-
Yamamoto, Y.1
Hirose, H.2
Miyashita, K.3
Nishikai, K.4
Saito, I.5
Taniyama, M.6
Tomita, M.7
Saruta, T.8
-
29
-
-
0020664271
-
Obesity. A report of the Royal College of Physicians
-
1983 Obesity. A report of the Royal College of Physicians. J R Coll Physicians Lond 17:5-65
-
(1983)
J R Coll Physicians Lond
, vol.17
, pp. 5-65
-
-
-
30
-
-
0001217801
-
Diagnostic criteria for polycystic ovary sindrome: Towards a rationale approach
-
Dunaif A, Given JR, Haseltine F, Merriam GR, eds. Boston: Blackwell
-
Zawdaki JK, Dunaif A 1992 Diagnostic criteria for polycystic ovary sindrome: towards a rationale approach. In: Dunaif A, Given JR, Haseltine F, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell; 377-384
-
(1992)
Polycystic Ovary Syndrome
, pp. 377-384
-
-
Zawdaki, J.K.1
Dunaif, A.2
-
31
-
-
0024306471
-
Evaluation of WHO and NDDG criteria for impaired glucose tolerance. Results from two national samples
-
Modan M, Harris MI, Halkin H 1989 Evaluation of WHO and NDDG criteria for impaired glucose tolerance. Results from two national samples. Diabetes 38:1630-1635
-
(1989)
Diabetes
, vol.38
, pp. 1630-1635
-
-
Modan, M.1
Harris, M.I.2
Halkin, H.3
-
32
-
-
0034854786
-
Growth hormone secretion after baclofen administration in different phases of the menstrual cycle in healthy women
-
Orio Jr F, Palomba S, Colao A, Tenuta M, Dentico C, Petretta M, Lombardi G, Nappi C, Orio F 2001 Growth hormone secretion after baclofen administration in different phases of the menstrual cycle in healthy women. Horm Res 55:131-136
-
(2001)
Horm Res
, vol.55
, pp. 131-136
-
-
Orio Jr., F.1
Palomba, S.2
Colao, A.3
Tenuta, M.4
Dentico, C.5
Petretta, M.6
Lombardi, G.7
Nappi, C.8
Orio, F.9
-
33
-
-
0037323477
-
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome
-
Orio Jr F, Falomba S, Di Biase S, Colao A, Tauchmanova L, Savastano S, Labella D, Russo T, Zullo F, Lombardi G 2003 Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:942-945
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 942-945
-
-
Orio Jr., F.1
Falomba, S.2
Di Biase, S.3
Colao, A.4
Tauchmanova, L.5
Savastano, S.6
Labella, D.7
Russo, T.8
Zullo, F.9
Lombardi, G.10
-
34
-
-
0037323477
-
Circulating ghrelin concentrations in the polycystic ovary syndrome
-
Orio Jr F, Lucidi P, Palomba S, Tauchmanovà L, Cascella T, Russo T, Zullo F, Colao A, Lombardi G, De Feo P 2003 Circulating ghrelin concentrations in the polycystic ovary syndrome. J Clin Endocrinol Metab 88:673-679
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 673-679
-
-
Orio Jr., F.1
Lucidi, P.2
Palomba, S.3
Tauchmanovà, L.4
Cascella, T.5
Russo, T.6
Zullo, F.7
Colao, A.8
Lombardi, G.9
De Feo, P.10
-
35
-
-
0032752208
-
Long-term administration of tibolone plus gonadotropin-releasing hormone agonist for the treatment of uterine leiomyomas: Effectiveness and effects on vasomotor symptoms, bone mass, and lipid profiles
-
Palomba S, Affinito P, Di Carlo C, Bifulco G, Nappi C 1999 Long-term administration of tibolone plus gonadotropin-releasing hormone agonist for the treatment of uterine leiomyomas: effectiveness and effects on vasomotor symptoms, bone mass, and lipid profiles. Fertil Steril 72:889-895
-
(1999)
Fertil Steril
, vol.72
, pp. 889-895
-
-
Palomba, S.1
Affinito, P.2
Di Carlo, C.3
Bifulco, G.4
Nappi, C.5
-
36
-
-
0036257524
-
Evaluation of assays available to measure free testosterone
-
Morley JE, Patrick P, Perry III HM 2002 Evaluation of assays available to measure free testosterone. Metabolism 5:554-559
-
(2002)
Metabolism
, vol.5
, pp. 554-559
-
-
Morley, J.E.1
Patrick, P.2
Perry III, H.M.3
-
37
-
-
0021813187
-
Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
-
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
-
(1985)
Diabetologia
, vol.28
, pp. 412-419
-
-
Matthews, D.R.1
Hosker, J.P.2
Rudenski, A.S.3
Naylor, B.A.4
Treacher, D.F.5
Turner, R.C.6
-
38
-
-
0024284028
-
A simple salting-out procedure for extracting DNA from human nucleated cells
-
Miller SA, Dykes DD, Polesky HF 1988 A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
-
(1988)
Nucleic Acids Res
, vol.16
, pp. 1215
-
-
Miller, S.A.1
Dykes, D.D.2
Polesky, H.F.3
-
39
-
-
0001491179
-
Impact of the peroxisome proliferator-activated receptor γ2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus
-
Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Auwerx J, Deeb SS, Amouyel P 2000 Impact of the peroxisome proliferator-activated receptor γ2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus. Int J Obes Relat Metab Disord 24:195-199
-
(2000)
Int J Obes Relat Metab Disord
, vol.24
, pp. 195-199
-
-
Meirhaeghe, A.1
Fajas, L.2
Helbecque, N.3
Cottel, D.4
Auwerx, J.5
Deeb, S.S.6
Amouyel, P.7
-
40
-
-
0035062772
-
A Pro12Ala polymorphism in the human peroxisome proliferators-activated receptor-γ 2 is associated with combined hyperlipidaemia in obesity
-
Swarbrick MM, Chapman CM, McQuillan BM, Hung J, Thompson PL, Beilby JP 2001 A Pro12Ala polymorphism in the human peroxisome proliferators-activated receptor-γ 2 is associated with combined hyperlipidaemia in obesity. Eur J Endocrinol 144:277-282
-
(2001)
Eur J Endocrinol
, vol.144
, pp. 277-282
-
-
Swarbrick, M.M.1
Chapman, C.M.2
McQuillan, B.M.3
Hung, J.4
Thompson, P.L.5
Beilby, J.P.6
-
41
-
-
0035093082
-
Effect of the peroxisome proliferator-activated receptor-2 Pro12Ala variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds
-
Hasstedt SJ, Ren QF, Teng K, Elbein SC 2001 Effect of the peroxisome proliferator-activated receptor-2 Pro12Ala variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds. J Clin Endocrinol Metab 86:536-541
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 536-541
-
-
Hasstedt, S.J.1
Ren, Q.F.2
Teng, K.3
Elbein, S.C.4
-
42
-
-
0034186496
-
Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-2 in Korean diabetic and obese subjects
-
Oh EY, Min KM, Chung JH, Min YK, Lee MS, Kim KW, Lee MK 2000 Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-2 in Korean diabetic and obese subjects. J Clin Endocrinol Metab 85:1801-1804
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 1801-1804
-
-
Oh, E.Y.1
Min, K.M.2
Chung, J.H.3
Min, Y.K.4
Lee, M.S.5
Kim, K.W.6
Lee, M.K.7
-
43
-
-
4243353569
-
Studies of the Pro12Ala polymorphism of the PPAR gene in the Danish MONICA cohort: Homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome
-
Frederiksen L, Brødbæk K, Fenger M, Jørgensen T, Borch-Johnsen K, Madsbad S, Urhammer SA 2002 Studies of the Pro12Ala polymorphism of the PPAR gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome. J Clin Endocrinol Metab 87:3989-3992
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 3989-3992
-
-
Frederiksen, L.1
Brødbæk, K.2
Fenger, M.3
Jørgensen, T.4
Borch-Johnsen, K.5
Madsbad, S.6
Urhammer, S.A.7
-
44
-
-
6344251826
-
2 gene Pro12Ala polymorphism may influence serum level of an adipocyte-derived protein, adiponectin, in the Japanese population
-
2 gene Pro12Ala polymorphism may influence serum level of an adipocyte-derived protein, adiponectin, in the Japanese population. Metabolism 52:798-799
-
(2003)
Metabolism
, vol.52
, pp. 798-799
-
-
Yamamoto, Y.1
-
45
-
-
0032589053
-
The PPARγ2 amino acid polymorphism Pro12Ala is prevalent in offspring of type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects
-
Koch M, Rett K, Maerker E, Volk A, Haist K, Deninger M, Renn W, Haring HU 1999 The PPARγ2 amino acid polymorphism Pro12Ala is prevalent in offspring of type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects. Diabetologia 42:758-762
-
(1999)
Diabetologia
, vol.42
, pp. 758-762
-
-
Koch, M.1
Rett, K.2
Maerker, E.3
Volk, A.4
Haist, K.5
Deninger, M.6
Renn, W.7
Haring, H.U.8
-
46
-
-
0034745183
-
Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-γ2 gene is associated with increased antilipolytic insulin sensitivity
-
Stumvoll M, Wahl HG, Loblein K, Becker R, Machicao F, Jacob S, Haring H 2001 Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-γ2 gene is associated with increased antilipolytic insulin sensitivity. Diabetes 50:876-881
-
(2001)
Diabetes
, vol.50
, pp. 876-881
-
-
Stumvoll, M.1
Wahl, H.G.2
Loblein, K.3
Becker, R.4
Machicao, F.5
Jacob, S.6
Haring, H.7
-
47
-
-
0031456016
-
Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis
-
Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774-800
-
(1997)
Endocr Rev
, vol.18
, pp. 774-800
-
-
Dunaif, A.1
-
48
-
-
0035663963
-
Endogenous glucose production is inhibited by the adipose-derived protein Acrp-30
-
Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L 2001 Endogenous glucose production is inhibited by the adipose-derived protein Acrp-30. J Clin Invest 108:1875-1881
-
(2001)
J Clin Invest
, vol.108
, pp. 1875-1881
-
-
Combs, T.P.1
Berg, A.H.2
Obici, S.3
Scherer, P.E.4
Rossetti, L.5
-
49
-
-
0037540732
-
Resistin and adiponectin expression in visceral fat of obese rats: Effect of weight loss
-
Milan G, Granzotto M, Scarda A, Calcagno A, Pagano C, Federspil G, Vettor R 2002 Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes Res 10:1095-1103
-
(2002)
Obes Res
, vol.10
, pp. 1095-1103
-
-
Milan, G.1
Granzotto, M.2
Scarda, A.3
Calcagno, A.4
Pagano, C.5
Federspil, G.6
Vettor, R.7
-
50
-
-
0036875579
-
Insulin decreases human adiponectin plasma levels
-
Mohlig M, Wegewitz U, Osterhoff M, Isken F, Ristow M, Pfeiffer AF, Spranger J 2002 Insulin decreases human adiponectin plasma levels. Horm Metab Res 34:655-658
-
(2002)
Horm Metab Res
, vol.34
, pp. 655-658
-
-
Mohlig, M.1
Wegewitz, U.2
Osterhoff, M.3
Isken, F.4
Ristow, M.5
Pfeiffer, A.F.6
Spranger, J.7
-
51
-
-
0036724336
-
Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein
-
Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T, Matsuzawa Y 2002 Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51:2734-2741
-
(2002)
Diabetes
, vol.51
, pp. 2734-2741
-
-
Nishizawa, H.1
Shimomura, I.2
Kishida, K.3
Maeda, N.4
Kuriyama, H.5
Nagaretani, H.6
Matsuda, M.7
Kondo, H.8
Furuyama, N.9
Kihara, S.10
Nakamura, T.11
Tochino, Y.12
Funahashi, T.13
Matsuzawa, Y.14
|